CTRI/2023/09/057988
Not yet recruiting
未知
A comparative study between intralesional injection of Bleomycin and Triamcinolone acetonide in the treatment of keloids. - nil
Dr Divya Ravali Bandaru0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: L910- Hypertrophic scar
- Sponsor
- Dr Divya Ravali Bandaru
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with clinically diagnosed keloid present on trunk, aged above 18 years and willing for regular follow\-up.
Exclusion Criteria
- •Active inflammation, infection or ulcer in or around the keloid.
- •Patients who received treatment for the same keloid in the past six months
- •Pregnancy, lactation, chronic renal failure, bleeding tendencies.
- •Those who develop a hypersensitive or an idiosyncratic reaction to bleomycin.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Comparison of the effect of intralesional injection of triamcinolone acetonide with the simultaneous combination of triamcinolone acetonide and 5-fluoracilHypertrophic scar.IRCT20130812014333N189Kermanshah University of Medical Sciences40
Recruiting
Phase 3
Effect of injection of methotrexate or triamcinolone in the nail for treatment of nail psoriasisail psoriasis.Other psoriasisL40.8IRCT20140212016557N7Shiraz University of Medical Sciences78
Completed
Not Applicable
Study of efficacy injection tuberculin in the treatment of wartsMultiple common warts.Viral wartsIRCT2015080323486N1Ahvaz Jundishapur University of Medical Sciences, Vice chancellor for research54
Recruiting
Phase 3
Effectiveness of steroid injection with and without cryotherapy in the treatment of keloid scarsKeloid.Acne keloidL73.0IRCT20230124057201N2Tehran University of Medical Sciences32
Completed
Not Applicable
Comparison of combined intralesional injection of glucantime and interferon gamma with intralesional glucantime alone in the treatment of cutaneous leishmaniasisCutaneous Leishmaniasis.Protozoal diseasesB50,B51,B5IRCT2015012420740N2Mashhad University of Medical Sciences, Vice Chancellor for Research90